Company
Cirrus Therapeutics
Cirrus Therapeutics is leveraging ocular immunology to create transformative therapies, designed to extend ocular healthspan and redefine healthy aging for vision.
Also known as Cirrus Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Cambridge, MA, United States
- Legal name
- Cirrus Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Cirrus Therapeutics is revolutionizing the treatment of age-related macular degeneration (AMD) with groundbreaking therapies that restore what aging takes away from our vision.
Funding snapshot
- Total raised
- $6.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $6.7M2025-08-04
Funding rounds
- Round, 2025
- $6.7M2025-08-04, SEC form D sold, 8 investors
Loading relationship preview